PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.19%
Revenue growth under 50% of 2127.T's 26.50%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.77%
Gross profit growth under 50% of 2127.T's 15.44%. Michael Burry would be concerned about a severe competitive disadvantage.
-21.19%
Negative EBIT growth while 2127.T is at 34.33%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-22.23%
Negative operating income growth while 2127.T is at 33.17%. Joel Greenblatt would press for urgent turnaround measures.
9.10%
Net income growth under 50% of 2127.T's 34.99%. Michael Burry would suspect the firm is falling well behind a key competitor.
9.10%
EPS growth under 50% of 2127.T's 35.02%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
9.10%
Diluted EPS growth under 50% of 2127.T's 35.02%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
15.38%
Dividend growth of 15.38% while 2127.T is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
145.37%
10Y revenue/share CAGR under 50% of 2127.T's 371.29%. Michael Burry would suspect a lasting competitive disadvantage.
35.19%
5Y revenue/share CAGR under 50% of 2127.T's 150.03%. Michael Burry would suspect a significant competitive gap or product weakness.
31.75%
3Y revenue/share CAGR under 50% of 2127.T's 142.04%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
144.02%
Below 50% of 2127.T's 433.32%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
19.91%
Below 50% of 2127.T's 247.76%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
28.78%
Below 50% of 2127.T's 361.91%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
295.46%
10Y equity/share CAGR 1.25-1.5x 2127.T's 253.30%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
76.61%
5Y equity/share CAGR above 1.5x 2127.T's 35.11%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.05%
Positive short-term equity growth while 2127.T is negative. John Neff sees a strong advantage in near-term net worth buildup.
361.54%
10Y dividend/share CAGR at 75-90% of 2127.T's 405.26%. Bill Ackman might push for a stronger payout policy to match the competitor’s returns.
150.00%
5Y dividend/share CAGR above 1.5x 2127.T's 60.00%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
87.50%
Below 50% of 2127.T's 1100.00%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
1721.43%
AR growth well above 2127.T's 210.84%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.84%
Inventory growth of 4.84% while 2127.T is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
10.68%
Asset growth at 50-75% of 2127.T's 15.03%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.47%
Under 50% of 2127.T's 9.90%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
75.11%
Debt growth of 75.11% while 2127.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
8.24%
We expand SG&A while 2127.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.